Paul M. Silva, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,551 shares at $210.13 ($1.6M) on 2021-03-01, disclosed to the SEC on 2021-03-02.
Open-market sale of $1.6M VRTX by SVP & Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $212.42 | 2,218 | $471K | 29.5% |
| 2 | $210.13 | 1,026 | $216K | 13.5% |
| 3 | $210.13 | 1,026 | $216K | 13.5% |
| 4 | $211.45 | 610 | $129K | 8.1% |
| 5 | $211.45 | 610 | $129K | 8.1% |
| 6 | $212.51 | 915 |
| $194K |
| 12.2% |
| 7 | $212.51 | 915 | $194K | 12.2% |
| 8 | $213.12 | 231 | $49K | 3.1% |
| Total | $211.68 avg | 7,551 | $1.6M | 100% |
| Filing → |
| VRTX | SELL | 2021-02-16 | $586K | — | Filing → |
| VRTX | SELL | 2020-08-10 | $564K | — | Filing → |
| VRTX | SELL | 2020-08-05 | $431K | — | Filing → |